Literature DB >> 21659361

Efficacy of prolonged therapy with combined arsenic trioxide and ATRA for relapse of acute promyelocytic leukemia.

Massimo Breccia, Laura Cicconi, Clara Minotti, Roberto Latagliata, Laura Giannì, Francesco Lo-Coco.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21659361      PMCID： PMC3166113          DOI： 10.3324/haematol.2011.045500

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  8 in total

1.  Promyelocytic sarcoma of the spine: a case report and review of the literature.

Authors:  Leonardo Pacilli; Francesco Lo Coco; Safaa Mahmoud Ramadan; Laura Giannì; Alberto Pingi; Daniele Remotti; Ignazio Majolino
Journal:  Adv Hematol       Date:  2010-03-18

2.  Use of all-trans retinoic acid plus arsenic trioxide as an alternative to chemotherapy in untreated acute promyelocytic leukemia.

Authors:  Elihu Estey; Guillermo Garcia-Manero; Alessandra Ferrajoli; Stefan Faderl; Srdan Verstovsek; Dan Jones; Hagop Kantarjian
Journal:  Blood       Date:  2005-12-22       Impact factor: 22.113

3.  Successful pregnancy after arsenic trioxide therapy for relapsed acute promyelocytic leukaemia.

Authors:  Emanuele Ammatuna; Annafranca Cavaliere; Mariadomenica Divona; Sergio Amadori; Giovanni Scambia; Francesco Lo-Coco
Journal:  Br J Haematol       Date:  2009-05-26       Impact factor: 6.998

Review 4.  Modern approaches to treating acute promyelocytic leukemia.

Authors:  Miguel A Sanz; Francesco Lo-Coco
Journal:  J Clin Oncol       Date:  2011-01-10       Impact factor: 44.544

5.  Autologous stem cell transplantation for patients with acute promyelocytic leukemia in second molecular remission.

Authors:  Felicetto Ferrara; Olimpia Finizio; Tiziana Izzo; Cira Riccardi; Clelia Criscuolo; Antonella Carbone; Erika Borlenghi; Giuseppe Rossi
Journal:  Anticancer Res       Date:  2010-09       Impact factor: 2.480

6.  Effective treatment of acute promyelocytic leukemia with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab ozogamicin.

Authors:  Farhad Ravandi; Eli Estey; Dan Jones; Stefan Faderl; Susan O'Brien; Jackie Fiorentino; Sherry Pierce; Deborah Blamble; Zeev Estrov; William Wierda; Alessandra Ferrajoli; Srdan Verstovsek; Guillermo Garcia-Manero; Jorge Cortes; Hagop Kantarjian
Journal:  J Clin Oncol       Date:  2008-12-15       Impact factor: 44.544

Review 7.  Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet.

Authors:  Miguel A Sanz; David Grimwade; Martin S Tallman; Bob Lowenberg; Pierre Fenaux; Elihu H Estey; Tomoki Naoe; Eva Lengfelder; Thomas Büchner; Hartmut Döhner; Alan K Burnett; Francesco Lo-Coco
Journal:  Blood       Date:  2008-09-23       Impact factor: 22.113

8.  Combined treatment with arsenic trioxide and all-trans-retinoic acid in patients with relapsed acute promyelocytic leukemia.

Authors:  Emmanuel Raffoux; Philippe Rousselot; Jöel Poupon; Marie-Thérèse Daniel; Bruno Cassinat; Richard Delarue; Anne-Laure Taksin; Delphine Réa; Agnès Buzyn; Annick Tibi; Geneviève Lebbé; Patricia Cimerman; Christine Chomienne; Jean-Paul Fermand; Hugues de Thé; Laurent Degos; Olivier Hermine; Hervé Dombret
Journal:  J Clin Oncol       Date:  2003-06-15       Impact factor: 44.544
  8 in total
  9 in total

1.  Allogeneic stem cell transplantation for advanced acute promyelocytic leukemia in the ATRA and ATO era.

Authors:  Safaa M Ramadan; Ambra Di Veroli; Agnese Camboni; Massimo Breccia; Anna Paola Iori; Franco Aversa; Luca Cupelli; Cristina Papayannidis; Andrea Bacigalupo; William Arcese; Francesco Lo-Coco
Journal:  Haematologica       Date:  2012-06-11       Impact factor: 9.941

Review 2.  Has Hematopoietic Stem Cell Transplantation a Role in the Treatment of Children and Adolescents with Acute Promyelocytic Leukemia?

Authors:  Anna Maria Testi; Paolo Musiu; Maria Luisa Moleti; Saveria Capria; Walter Barberi
Journal:  Mediterr J Hematol Infect Dis       Date:  2022-05-01       Impact factor: 3.122

Review 3.  Current first- and second-line treatment options in acute promyelocytic leukemia.

Authors:  Fulvio Massaro; Matteo Molica; Massimo Breccia
Journal:  Int J Hematol Oncol       Date:  2017-02-02

4.  Fucoidan enhances the therapeutic potential of arsenic trioxide and all-trans retinoic acid in acute promyelocytic leukemia, in vitro and in vivo.

Authors:  Farzaneh Atashrazm; Ray M Lowenthal; Joanne L Dickinson; Adele F Holloway; Gregory M Woods
Journal:  Oncotarget       Date:  2016-07-19

5.  Treatment for relapsed acute promyelocytic leukemia: what is the best post-remission treatment?

Authors:  Gi-June Min; Byung-Sik Cho; Sung-Soo Park; Silvia Park; Young-Woo Jeon; Seung-Ah Yahng; Seung-Hawn Shin; Jae-Ho Yoon; Sung-Eun Lee; Ki-Seong Eom; Yoo-Jin Kim; Seok Lee; Chang-Ki Min; Seok-Goo Cho; Jong Wook Lee; Hee-Je Kim
Journal:  Blood Res       Date:  2022-07-27

Review 6.  Management of elderly patients with acute promyelocytic leukemia: progress and problems.

Authors:  Eva Lengfelder; Wolf-Karsten Hofmann; Florian Nolte
Journal:  Ann Hematol       Date:  2013-05-22       Impact factor: 3.673

7.  Management of acute promyelocytic leukemia in the elderly.

Authors:  Francesco Lo-Coco; Roberto Latagliata; Massimo Breccia
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-06-08       Impact factor: 2.576

8.  Treatment outcomes in relapsed acute promyelocytic leukemia patients initially treated with all-trans retinoic acid and arsenic compound-based combined therapies.

Authors:  Jin Lu; Xiaojun Huang; Li Bao; Hao Jiang; Honghu Zhu; Bin Jiang
Journal:  Oncol Lett       Date:  2013-10-25       Impact factor: 2.967

9.  A Set of 17 microRNAs Common for Brain and Cerebrospinal Fluid Differentiates Primary Central Nervous System Lymphoma from Non-Malignant Brain Tumors.

Authors:  Maria Sromek; Grzegorz Rymkiewicz; Agnieszka Paziewska; Lukasz Michal Szafron; Maria Kulecka; Michalina Zajdel; Mariusz Kulinczak; Michalina Dabrowska; Aneta Balabas; Zbigniew Bystydzienski; Magdalena Chechlinska; Jan Konrad Siwicki
Journal:  Biomolecules       Date:  2021-09-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.